7 citations
,
January 2022 in “Evidence-based complementary and alternative medicine” This study found that ginger supplementation significantly improved persistent hypothyroid symptoms and may aid in weight and lipid profile management in hypothyroid patients with normal TSH levels.
This case series observed that patients with persistent post-COVID-19 symptoms reported considerable improvement after using icosapent ethyl, suggesting potential therapeutic success warranting further research.
December 2016 in “Journal of Evolution of Medical and Dental Sciences” This case report highlights that inherited zinc deficiency can persist into adulthood and emphasizes the importance of selecting optimal chelating agents to improve oral zinc bioavailability.
March 2022 in “Biomedical Journal of Scientific & Technical Research” This review discusses therapeutics for mitochondrial dysfunction and reports no new clinical findings.
73 citations
,
July 2013 in “The Journal of Sexual Medicine” This study observed that androgenic alopecia patients taking finasteride had altered neuroactive steroid levels and persistent depression symptoms even after stopping the treatment.
39 citations
,
October 2015 in “Case Reports” In this case series, four adults developed severe, disabling multisymptom illness potentially linked to fluoroquinolone use, which persisted and progressed even after discontinuation of the drug.
2 citations
,
September 2022 in “Frontiers in Nutrition” This study found no significant difference in the persistence of new symptoms or quality of life improvements with 200,000 IU of vitamin D3 compared to placebo in patients post-COVID-19 hospitalization.
1 citations
,
December 2022 in “Journal of Family Medicine and Primary Care” This study found that post-COVID-19 syndrome led to long-term health issues for many participants, underscoring the need for preventive measures and patient-centered programs to reduce complications.
54 citations
,
May 2018 in “International journal of risk & safety in medicine” This study observed enduring sexual dysfunction reported in 300 cases globally following the use of SSRIs, finasteride, and isotretinoin, with common symptoms like genital anaesthesia and loss of libido.
33 citations
,
October 2017 in “Drug Safety” SJS/TEN survivors often have severe, overlooked long-term physical problems that are not properly treated after leaving the hospital.
2 citations
,
September 2021 in “Orphanet Journal of Rare Diseases” In this study, HED patients with COVID-19 showed a higher risk of postinfection fatigue and hair loss compared to controls, suggesting they are more susceptible to long-term consequences of SARS-CoV-2 infection.
This study found that systemic lupus erythematosus was diagnosed earlier in males than females, with a notable delay in diagnosis for females often due to confounding symptom overlaps with other conditions.
April 2026 in “Journal of Clinical Medicine” In this study, men with previous finasteride use reported more severe sexual and psychological symptoms with greater cumulative exposure and older age, highlighting a need for further research on risk factors and long-term impacts.
May 2026 in “Pacific Rim International Journal of Nursing Research” In this study of Thai women with ovarian cancer receiving chemotherapy, researchers found that symptom experiences such as numbness, tingling, and fatigue were frequent and significantly affected quality of life, while the effectiveness of symptom management did not significantly predict quality of life.
This narrative review concludes that long-term randomized controlled trials are needed to establish clear guidelines for testosterone therapy in women, given the lack of FDA-approved formulations and the variable quality of current treatments.
141 citations
,
September 2016 in “European Journal of Dermatology” This review examines dermatological side effects of taxane chemotherapy reported in past studies and highlights the necessity for identifying and managing these conditions to maintain cancer patients' quality of life; it presents no new clinical results.
8 citations
,
October 2022 in “Medicina-lithuania” This study observed that long COVID symptoms differed between patients infected in the Delta and Omicron periods, with those in the Omicron period experiencing milder illnesses but more fatigue, insomnia, and cough.
8 citations
,
October 2021 in “bioRxiv (Cold Spring Harbor Laboratory)” This study found that healthcare workers with a positive SARS-CoV-2 nasopharyngeal swab were most likely to report long-COVID symptoms, while seropositive workers without a positive swab had milder symptoms.
2 citations
,
May 2012 in “Annals of Oncology” This study found that patients with ovarian metastases from breast cancer had a better prognosis after tumor debulking if they exhibited high estrogen and progesterone receptor expression in both the primary tumor and metastases.
1 citations
,
August 2023 in “Frontiers in immunology” This review highlights the potential of TCM medicinal foods for managing post-COVID disorders and suggests they could provide a safe and efficient long-term therapy due to their milder nature.
14 citations
,
August 2018 in “Frontiers in Cellular and Infection Microbiology” This study found that dengue virus infection caused inflammation and cell death in human hair-follicle dermal papilla cells, which may contribute to increased hair shedding observed during the epidemic in Taiwan.
October 2021 in “International Journal of Andrology” This paper reports on the controversy surrounding post-finasteride syndrome and questions Merck and the FDA's handling of associated sexual side effects. Despite significant adverse event reports, both entities failed to conduct further studies or enhance patient safety warnings about finasteride's long-term effects.
4 citations
,
May 2022 in “Medicina” In this study, Kampo medicine was frequently prescribed for general fatigue in long COVID, particularly the formula hochuekkito, suggesting its potential as a treatment option.
8 citations
,
June 2021 in “Annals of internal medicine” This article discusses the evaluation and management of long COVID, emphasizing the need for a multidisciplinary approach and coordinated efforts in both research and patient care but reports no new findings.
202 citations
,
January 2022 in “Journal of Clinical Medicine” This study found that female COVID-19 survivors were more likely than males to experience multiple long-term post-COVID symptoms, including fatigue, pain, hair loss, and mood disorders.
1 citations
,
April 2020 in “Indian Journal of Rheumatology” This study found that 42% of patients with systemic lupus erythematosus in India had thyroid dysfunction, predominantly hypothyroidism, which was independent of lupus disease activity.
12 citations
,
February 2012 in “New England journal of medicine/The New England journal of medicine” This clinical case report describes a 72-year-old man who experienced significant weight loss and frequent loose stools over eight months, presenting with fatigue.
1 citations
,
July 2018 in “Current Sexual Health Reports” This review discusses the occurrence of persistent sexual, physical, neurological, and psychiatric side effects known as post-finasteride syndrome after 5x-reductase inhibitor treatment, and emphasizes the importance of evaluating these risks for patients with benign prostatic hyperplasia or androgenic alopecia.
February 2023 in “Journal of clinical medicine research” This study found that zinc acetate hydrate may improve fatigue and hair loss symptoms in post-COVID-19 patients.
January 2020 in “Archives of urology” This review discusses concerns about persistent side effects of finasteride, such as sexual dysfunction and suicidal ideation, urging the medical community to recognize and address these issues.